Sterility
Conditions
Brief summary
To assess the effectiveness of a protocol of ovarian hyperstimulation with urinary gonadotrophins, to achieve clinical pregnancy in females undergoing IVF. Study hypothesis: to assess the effectiveness of a protocol of urinary gonadotrophins
Interventions
DRUGhMG-HP
Sponsors
Ferring SAU
Ferring Pharmaceuticals
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 38 Years
Healthy volunteers
No
Inclusion criteria
* Women aged 18-38 years * Body mass index (BMI) between 18 and 30 * Women classified as normogonadotrophin patients. Not more than 3 previous cycles of ART (assisted reproductive technology) * Testosterona, FSH (follicle-stimulating hormone) LH (luteinizing hormone) and Prolactin serum levels during the early folicular phase (days 2-4 of the cycle) within the laboratory normal range * No administration of clomiphen citrate or gonadotropins during the month prior to the start of the study
Exclusion criteria
* Failure in previous cycles of assisted reproduction IVF/ICSI (in-vitro fertilisation/intracytoplasmic sperm injection) * Seminal samples not apt for IVF-ICSI (according to the criteria of each center). Evidence of significant bacterial infection in the seminogram of the couple in the preceding 6 months * Data suggestive of possible ovarian failure * Antecedents of severe ovarian hyperstimulation syndrome (OHSS) * Important systemic disease * Pregnancy or contraindication to pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy rate | 30 days |
Secondary
| Measure | Time frame |
|---|---|
| Biochemical pregnancy rate | 16 days |
Countries
Spain
Outcome results
None listed